See also stories tagged with Molecule
An international research team, led by Justus Liebig University Giessen (JLU), the Institute for Lung Health (ILH) in Giessen, and the Max Planck Institute for Heart and Lung Research in Bad Nauheim, has identified a promising ...
Jun 8, 2026
0
7
Researchers in the lab of Cancer Center at Illinois (CCIL) member Xing Wang have discovered the influential role of structural chirality, or "handedness," of a DNA nanostructure to dictate cancer cell response to targeted ...
Jun 8, 2026
0
6
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator ...
Jun 8, 2026
0
26
"Compound 10" is how Ursula Quitterer refers to the chemical compound that her team has developed and that could slow the progression of Alzheimer's disease. Quitterer is a professor of molecular pharmacology at ETH Zurich ...
Jun 8, 2026
0
14
Huntington disease is a rare, inherited brain disorder that progressively destroys nerve cells, leading to worsening movement, cognitive and psychiatric symptoms. Caused by a mutation in the huntingtin gene, the fatal disease ...
Jun 8, 2026
0
11
An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as non-muscle-invasive bladder cancer, is now being repurposed to address one of the biggest public health ...
It's no accident that we spend a third of our lives asleep. It is essential to our health, and even animals for whom resting is complicated—such as aquatic mammals that need to surface to breathe, or birds that go up to 10 ...
Jun 7, 2026
0
26
For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.
Jun 6, 2026
0
13
Chromosomal instability is a common feature in many solid tumors and is associated with greater aggressiveness. For years, its main contribution to cancer was thought to be driving the evolution of tumor genomes, causing ...
Jun 6, 2026
0
12
In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM, from Biogen) and donanemab (Kisunla, from Eli Lilly and Co.), both based on immunotherapy (the use of molecules ...
Jun 6, 2026
0
10
